How Can We Encourage Minorities to Join Cancer Clinical Trials?
In the effort to include more diverse patient populations in clinical trials, good intentions can easily go awry. Panelists...
Category: Featured
In the effort to include more diverse patient populations in clinical trials, good intentions can easily go awry. Panelists...
The injustices come in many ways. A transgender woman is admitted to the hospital for cancer treatment. Her physicians...
The 12th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved kicked...
Cancer researchers often focus on developing novel treatments or combining therapies in new ways, all with the goal of...
In recent decades, the cancer research community has made great strides by bringing new, targeted, safer, and longer-lasting treatments...
Pancreatic cancer is projected to become the second leading cause of cancer mortality in the United States by 2030....
September is Ovarian Cancer Awareness Month. It’s an apt time for the American Association for Cancer Research (AACR) Advances...
Policy plays a critical role in the fight against cancer, influencing the funding of cancer research and driving the...
Last week, the U.S. Food and Drug Administration (FDA) approved the second of a new wave of molecularly targeted...
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...